Pharma

Latest posts

Why we can’t trust billionaires with our health


25 October 2017

Morten Thaysen introduces our new campaign against the corporate control of medicine.

Are Big Pharma holding patients to ransom to boost their profits?


23 June 2017

The NHS has been forced into yet another secretive deal with a big pharmaceutical company to ensure access for cancer patients to the newest medicines. But while access to new drugs is obviously good news for cancer patients, the deal itself paints a bleak picture for the future of our NHS.

Latest news

Campaign groups Global Justice Now and STOPAIDS have welcomed a statement by NHS England to the BBC’s 5 Live Investigates this morning that “further regulatory action may be needed” on drug pricing at a time when NHS funding is under severe pressure.

Treatments for cancer, arthritis and multiple sclerosis (MS) are among drugs costing the cash-strapped NHS over a billion pounds a year – despite public funding playing a substantial role in the medicines’ development.

Resources

Sick of corporate greed leaflet

November 2017

Pharmaceuticals campaign leaflet

Imagine if the NHS couldn’t afford to save your life

November 2017

All over the world, drug companies are charging extortionate prices for medicine, preventing people accessing treatment.
It’s time to put people before profit in the global drug industry.

Resource thumbail

Pills and Profits: How drug companies make a killing out of public research

October 2017

UK taxpayers and patients worldwide are being denied the medicines they need, despite the public sector playing a pivotal role in the discovery of new medicines. The UK government is the second largest funder country, after the US, for research and development (R&D) in diseases that predominantly affect poor countries. Across all areas of health R&D, the UK government spent £2.3 billion on health R&D in 2015 alone.